
ã¢ã³ã㌠ããã¯ã¹(ãµã«ç)ãŒçå®ãšææã®ãã«ã
ãããŒãã»Wã»ãããŒã³å»åŠå士
MS
5æ21æ¥
å èšäºã¯ãã¡ãã
ãã®ãµã«çã®çºçã¯æ¬åœã®è åšãªã®ãããããšããèªåŒµããæŠåšåãããå ¬è¡è¡çã¡ãã»ãŒãžã®äžäŸãªã®ãïŒ
ãã®è³ªåã«å¯Ÿããç§ã®çãã¯æ¬çš¿ã®æåŸã«è²ãããšã«ããŠãããã§ã¯ãµã«çãšã¯äœããé¢é£ããç
æ°ã®æ§è³ªãšç¹åŸŽãåãã£ãŠããããšãšåãã£ãŠããªãããšã«çŠç¹ãåœãŠãããšæãã
ã¢ããªã«ã®åå°ãèµ·æºãšãããµã«çãŠã€ã«ã¹ã¯ããšãã«ãªã«ãœããã¯ã¹ãŠã€ã«ã¹å±ã®SmallPoxïŒVariolaïŒãšè¿çžã§ãããã ããVariolaïŒå€§ãŸãã¯å°ïŒã¯ãOrthopoxãŠã€ã«ã¹ãåŒãèµ·ããææªã®äººäœçŸæ£ã®åå ãšãªããŠã€ã«ã¹ã®çš®ã§ããããšãçè§£ããŠããå¿ èŠããããŸããäŸãã°ãççã銬çãé§±é§çããã®å±ã«å±ãããããããã人éã«ãšã£ãŠå€§ããªå¥åº·äžã®è åšã§ã¯ãªãããã®ãã¡ã®äžã€ïŒççïŒã¯ïŒæŽå²çã«ïŒå€©ç¶çã®ã¯ã¯ãã³ãšããŠäœ¿ãããŠããã»ã©ã§ãããç§ãèšãããã®ã¯ãç¿çã倩ç¶çãšé¢ä¿ããããããšãã£ãŠããããåæ§ã®å ¬è¡è¡çäžã®è åšããããããšããããšã§ã¯æ±ºããŠãªããšããããšã§ãããããã§ãªããšã»ã®ããã人ã¯ãåºæ¬çã«æŠåšåãããå ¬è¡è¡çé¢é£ã®ãããã¬ã³ãã«åŸäºããŠãããããããã¯ãããæ¯æããŠããã®ã§ãããèšãæããã°ãå ¬è¡è¡çã®ææãã«ããåºããŠããã®ã§ãã
ãµã«çã¯1958幎ã«ãµã«ã®ã³ãããŒã§åããŠç¢ºèªããã1970幎ã«ã³ã³ãŽæ°äž»å ±ååœã§æåã®ããã®ãŠã€ã«ã¹ææäŸã確èªããããã¢ããªã«ã«äœã人ã ã¯ãäœå幎ãã®éããµã«ãä»ã®ç¿çåç©ã®å®¿äž»ãšæ¥è§ŠããŠãããããããã¯ç¢ºèªãããæåã®çäŸã«éããªãå¯èœæ§ãé«ãã®ã§ãããçŸåšãã¢ããªã«ä»¥å€ã®å°åã§æµè¡ããŠããã西ã¢ããªã«ãã®ãµã«çïŒã¯ã¬ãŒãïŒå€çš®ïŒã¯ãã¢ããªã«ã®ä»ã®å°åã«èŠãããè¿çžã®ãŠã€ã«ã¹ïŒã³ã³ãŽã»ã¯ã¬ãŒãïŒã«æ¯ã¹ãŠããã軜ãç æ°ãåŒãèµ·ãããŸããÂ
ãµã«çã®çç¶ã¯å€©ç¶çã«äŒŒãŠããŸããã倩ç¶çãããã£ãšè»œãã§ãã西ã¢ããªã«ã®ãµã«çãŠã€ã«ã¹ã«ããæ¬çã®äžè¬çãªèšåºçç¶ã¯ãçºç±ãäœã®çã¿ãæªå¯ãªã©ã®ã€ã³ãã«ãšã³ã¶æ§çç¶ãšããªã³ãç¯ã®è
«è¹ã§ãããŸããææã«çºç¹ãèŠãããããšããããŸããåŸæã«ã¯ã1ã¶æä»¥äžç¶ãããšããããå°ããªç
å€ã䌎ããçç®ãã§ããå°ããªè²çŽ æ²çããç¢çãã§ããããšããããŸããç¡çç¶ææã®èšŒæ ã¯ãªããã€ãŸããçŸåšã®å»åŠçç¥èŠã§ã¯ãææããŠããªãå人ãšããã§ã«ç
æ°ã®çç¶ãåºãŠãã人ãšã®éã®äººå¯Ÿäººã®æ¥è§Šã«ãã£ãŠã®ã¿ææããããšãåãã£ãŠããŸãã
ãããã£ãŠãæ¥è§Šè
è¿œè·¡ãææè
ãšèäœçã«æ¥è§Šãã人ã®äžæçãªéé¢ãçç¶ãåºã人ã®é·æçãªéé¢ãšãã£ãå€å
žçãªå
¬è¡è¡çä»å
¥ã«ãã£ãŠãç
æ°ã®åºããã容æã«ã³ã³ãããŒã«ããããšãã§ããã®ã§ãã
çŸåšã欧米ã§å ±éãããŠããäºäŸã¯ãåºæ¬çã«ãã¹ãŠç·æ§ãšæ§äº€æžãæã€ç·æ§ã®éã§èµ·ãã£ãŠããã坿¥ãªèº«äœçæ¥è§Šãåå ã§ããããã«æãããŸãããµã«çã¯ã¢ããªã«ã®å€ãã®å°åã§æµè¡ããŠãããã人ç£å
±éææçãã®ãŠã€ã«ã¹ã§ããã€ãŸãããµã«ã ãã§ãªãæ§ã
ãªåç©ããããã«ææããå¯èœæ§ãããã®ã§ãã
ã¢ããªã«ã§äžè¬çã«èŠãããæ£çºçãªçäŸã¯ãæåã«åç©ãããããžææãããã®åŸãããããããžã®ææãéå®çã§ããããšãåå ã§ãããšæãããŸããæ°Žçã¯éåžžã«ææåã匷ãã®ã§ããã"ããã¯ã¹ "ãšããååã«ããããããããªãŒãœããã¯ã¹ãŠã€ã«ã¹å±ã«ã¯å±ããŠããŸãããããäžåºŠåŒ·èª¿ããŠãããŸãããççãšã©ã¯ãçããªãŒãœããã¯ã¹ãŠã€ã«ã¹å±ã§ã人éãææããŠãç¹ã«ç
åæ§ã¯ãããŸãããç¿çããªãŒãœããã¯ã¹ãŠã€ã«ã¹å±ã®ãçããŠã€ã«ã¹ã ãããšãã£ãŠãç¹ã«èŽæ»æ§ãããããã§ã¯ãããŸããã
ãµã«çã¯äºæ¬éDNAãŠã€ã«ã¹ã§ãDNAãäºæ¬éã§ãããããè€è£œæã«2æ¬ã®éã®ãããããããäžæ¹ã®éãããã§ãã¯ãããåããããããã®ããšã©ãŒãã§ãã¯ãã®çµæããã®ãŠã€ã«ã¹ãä»ã®DNAãŠã€ã«ã¹ã¯ãRNAãŠã€ã«ã¹ã«æ¯ã¹ãŠã¯ããã«ãã£ãããšå€ç°ããããŸããDNAãŠã€ã«ã¹ã®ã²ãã ã¯æ¯èŒçå®å®ããŠããŸãã
ã€ãŸããSARS-CoV-2ïŒCOVIDïŒãã€ã³ãã«ãšã³ã¶ãšã¯ç°ãªãããµã«ã¢ããã¯èªç¶ç²åŸå
ç«ãã¯ã¯ãã³èªå°å
ç«ããéããããã«æ¥éã«é²åããå¯èœæ§ã¯äœãã®ã§ãããã®ãããCOVID-19ã®åå ãŠã€ã«ã¹ã§ããSARS-CoV-2ã®ãããªæ¥éã«é²åããRNAã³ãããŠã€ã«ã¹ããããã¯ã¯ãã³è£œé ã®ç®çã§ã¯ã¯ããã«å®¹æãªã¿ãŒã²ãããšãªããããã«ãå
ç«åŠçãªèгç¹ããèŠããšãããŸããŸãªãªã«ãœããã¯ã¹ã»ãŠã€ã«ã¹ã¯ããã°ãã°çžäºé²åŸ¡çãªåœ¹å²ãæ
ã£ãŠããŸããã€ãŸãã倩ç¶çã¯ã¯ãã³ãæ¥çš®ãã人ããããã¯éå»ã«ççãé§±é§çãç¿çã«ææãã人ã¯ãçŸåšã¢ããªã«ä»¥å€ã®åœã§ïŒãããŸãã«ïŒå ±åãããŠããç¿çãŠã€ã«ã¹ã«ããç
æ°ã«ããªã匷ãå¯èœæ§ãããã®ã§ãã
çŸåšã®ããŒã¿ã§ã¯ããµã«çã¯äººéãžã®ææåã¯ããã»ã©é«ããããŸãããRoã¯äœãïŒãããã1以äžïŒãããã¯ææçã人éãã人éãžãšåºããå¹çã衚ãèšèã§ããããã¯ãææçããããããããžäŒæããå¹çã瀺ãçšèªã§ãå°ã蟌ãã®ããã«ã¯éåžžã«è¯ããã¥ãŒã¹ã§ããRoã1以äžãšããããšã¯ãäžè¬ã«ïŒç€ŸäŒçè·é¢ã眮ããªã©ã®å°ã蟌ãçããªãå Žåã§ãïŒããã§ã«ææããŠãã人1人ã«å¯ŸããŠãæ°ãã«ææãã人ãå¹³å1人以äžã§ããããšãæå³ããŸããæ¯èŒã®ãããSARS-CoV-2ã®ãªãã¯ãã³åã¯Roã7ãã10ã®ç¯å²ã«ãããRoã1æªæºã®ãŠã€ã«ã¹ã¯ãäžè¿°ã®æšæºçãªå ¬è¡è¡çæ³ã§å®¹æã«å°ã蟌ããããšãã§ãããããããRoã7ãã10ã®ãŠã€ã«ã¹ã¯åºæ¬çã«å°ã蟌ããããããªãã¯ãã³åã«èŠãããããã«ãäžçäžã«æ¥éã«æ¡æ£ããŠããã ãããRoã1以äžã®ãŠã€ã«ã¹ã®å Žåãæ¥è§Šè ã®è¿œè·¡ãææè ã®ç¹å®ãšéé¢ãšãã£ãåŸæ¥ã®ææç察çã§ãŠã€ã«ã¹ãå¶åŸ¡ããããšãã§ãããç¿çããããããããžäŒæããŠããããšã¯ãããŸãè¯ããã¥ãŒã¹ã§ã¯ãªããããã®äŒæã¯éåžžã«å¯æ¥ãªæ¥è§ŠããçããŠãããããªã®ã§ãäžè¬çãªã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ã«é Œãããšãªãã容æã«æå¶ããããšãã§ããããšãæå³ããããã®ãããªç°å¢ã§ã¯ã倧ããªæµè¡ããã£ãå Žåãã¯ã¯ãã³æ¥çš®ã¯ãææè ãšæ¥è§Šããå¯èœæ§ãæãé«ãå»çåŸäºè ãææ¥éå¡ã ãã«éå®ãããããšãå€ãã®ã§ãããªã³ã°ã¯ã¯ãã³ãåºåã¯ã¯ãã³æ¥çš®ã«ããå°ã蟌ãã«ã¯ã¯ãã³ã䜿çšããããšã¯ãäžè¬çã«äžèŠã§ãããã¯ã¯ãã³ã®å®å šæ§ã«ãã£ãŠã¯é广ã«ãªãå¯èœæ§ãããããŸã - ã©ããªè¬ãã¯ã¯ãã³ãå®å šã«å®å šã§ã¯ãªãããšã念é ã«çœ®ããŠãã ããã
ãã®ç¹ã説æããããã«ãå°ãå人çãªè©±ããããŠãã ãããççœèãå«ã9æ11æ¥ã®äºä»¶ã®åŸãç§ã¯ç±³åœåœé²ç·çïŒDoDïŒã®å¥çŽïŒDynport Vaccine Companyã«çºè¡ïŒã®ããšãå¹ åºãçç©é²è¡ã¯ã¯ãã³ã®èšåºéçºã«é¢ããä»äºã«å°±ããããã®äžã§ã倩ç¶çã®äºé²ãç®çãšããã¯ã¯ãã³ã®éçºã«æºãããŸãããåœæãç±³åœå¯å€§çµ±é ã®ãã£ãã¯ã»ãã§ã€ããŒæ°ã¯ã倩ç¶çãç±³åœã«åå°å ¥ããããã€ãªããæ»æã®å¯èœæ§ã1ïŒ çšåºŠãããšèãã倩ç¶çã¯ã¯ãã³ã®æ®åãæå±ããŠããŸãããæ¢åã®åŒ±æ¯ç倩ç¶çã¯ã¯ãã³ã¯ãå»çåŸäºè ã第äžå¿çè ã«å šç±³ã§é åããå§ããããããšãã¯ã¯ãã³ãåå ãšãªã被害ãè€æ°å ±åãããããã«ãªã£ãã®ã§ããç§ã¯ããã®ãããªãæå®³äºè±¡ãã«é¢ããåœé²ç·çã®æŽå²çãªå€©ç¶çã¯ã¯ãã³ãã£ã³ããŒã³ã®èšé²ã調ã¹ãä»äºãä»»ãããŸããããã®åŒ±æ¯çã¯ã¯ãã³æäžåŸã®æå®³äºè±¡ã¯ããç¥ãããŠãããäžè¬ã«2ã€ã®ã«ããŽãªãŒã«åé¡ãããŸãããããã±ãŒã¹ã§ã¯ãè¥ãå µå£«ãæ°å µã®äžéšã§ããããŸã§çºèŠãããŠããªãã£ãå ç«åŠçãªæ¬ é¥ãããããã®çµæãåœæäœ¿çšãããŠãã匱æ¯çã¯ã¯ãã³ã»ãŠã€ã«ã¹ã«ããç¶ç¶çãªææãåŒãèµ·ãããã®ã§ããããäžæ¹ã®ã°ã«ãŒãã¯ãã¯ã¯ãã³æ¥çš®ã«é¢é£ããççãå¿èçãªã©ããã埮åŠãªçç¶ãåããããã¯äžè¬çã«èªå·±å ç«éçšã«ãããã®ãšèããããŠããããããã®åé¡ã¯ã倩ç¶çã®äºé²æ¥çš®ãäžè¬çã§ãã£ãæä»£ïŒå€©ç¶çã¯æ ¹çµ¶ãããŠããªãã£ãïŒã«ç¥ãããŠãããªã¹ã¯ã§ããããããã£ãŠãåãã¯ã¯ãã³ãçŸåšã«åå±éããŠãé©ãã«ã¯ããããªãããããã倩ç¶çã¯æ ¹çµ¶ãããŠããããã§ã€ããŒæ°ã®ææªã®ã·ããªãªã¯èµ·ãããªãã£ããååšããªãè åšãã身ãå®ãããã«ã¯ã¯ãã³ãæ¥çš®ãã被害ãåãã人ã ã¯ããªã¹ã¯ãšå©çã®æ¯çãå®å šã«é転ããŠããããšã瀺ãè¯ãäŸã§ããããªã¹ã¯ã°ããã§ãããã£ããããªãããããŠãé©åã«å€©ç¶çã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ã¯äžæ¢ãããã
éèŠãªãã€ã³ãïŒ
ããã¯ã€ã³ãã«ãšã³ã¶ãCOVIDã§ã¯ãããŸããããã®ãŠã€ã«ã¹ã¯ãã£ãããšå€ç°ããææåã¯åŒ·ããªããèªç¶ç²åŸå ç«ã¯åŒ·åã§é·æéæç¶ããOrthopoxã¯ã¯ãã³ã¯éåžžã亀差é²åŸ¡å¹æããããŸããå ç«åŠçãªéé¿ã®ãªã¹ã¯ã¯éåžžã«äœãã®ã§ãããããŠããã®ãŠã€ã«ã¹ã®èå»¶ã¯ãåçŽã§å®äŸ¡ãªå€å žçå ¬è¡è¡ç察çã«ãã£ãŠå®¹æã«é»æ¢ããããšãã§ãããããããã§ãªããã°ãç§ãã¡ã¯ãã§ã«æ°å幎åã«ç¿çã®å€§æµè¡ãçµéšããŠããã¯ãã§ããã
ãµã«çã®éç床ã¯ãç°ãªãã¯ã¬ãŒãïŒã¢ããªã«ã®ç°ãªãå°åã§çºèŠããããã®ãŠã€ã«ã¹ãéåžžã«é·ãéååšããŠããããšã瀺åããŠããïŒã«ãã£ãŠç°ãªãå Žåãããã幞ããªããšã«ããã®ç¹å®ã®ã¯ã¬ãŒãã¯éç床ãäœããã¢ããªã«ã§æµè¡ããŠããããã§ããæ®å¿µãªããããããŸã§ã»ãšãã©ç ç©¶ãããŠããªãã£ãããããã®ãŠã€ã«ã¹ãšé¢é£ãã人äœçŸæ£ã«ã€ããŠã¯ãäžè¬äœæ°ãžã®ææè åšãéåžžã«äœãããšãäž»ãªçç±ã§ãæ¯èŒçç¥ãããŠããªããSTATãã¥ãŒã¹ã®ãžã£ãŒããªã¹ãã§ããHelen Branswellã¯ãæè¿CDCã®å°éå®¶ã«ã€ã³ã¿ãã¥ãŒããèšåºçç¶ã®åªããèŠçŽãçºè¡šããŠããã
ãçºç±ãã1ïœ3æ¥åŸã«ãå€ãã®å Žåãé¡é¢ããå§ãŸãç¹åŸŽçãªçºç¹ãåºçŸãããå€ãã®çŸæ£ãçºç¹ãåŒãèµ·ãããããµã«çã®çºç¹ã¯ãç¹ã«æã®ã²ãã«å°æ°Žç±ã圢æããããšãã§ãããšããçããç¹åŸŽãæã€ããµã«çãæµè¡ããŠããåœã§ã¯ãäž»ã«ææããåç©ã殺å·ããããé£çšã«ããããã«ããã·ã¥ããŒãã調çããéã«ããã®åç©ãã人ã«ãŠã€ã«ã¹ãåºãããšèããããŠããŸãã
ãŠã€ã«ã¹ã人ã«ç§»ããšãåŒåžåšé£æ²«ïŒãŠã€ã«ã¹ãå«ãã åŸæ¶²ãç®ã錻ãåã®ç²èã«ææããïŒãä»ããŠããããã¯ãµã«çã®ç å€ãäœæ¶²ãšã®æ¥è§Šã«ãããç®èã®å°ããªåãå£ãããŠã€ã«ã¹ãäŸµå ¥ãã人ããäººãžææããããšããããŸãããŸãããµã«çã®ç å·£ã®ç©è³ªã§æ±æãããè¡£é¡ããªãã³é¡ãšã®æ¥è§Šã§ãææããå¯èœæ§ããããŸãã(STATãã¥ãŒã¹ïŒã
ç±³åœã§ã¯2003幎ã«ãµã«çã®æµè¡ããããŸãããã¢ããªã«ä»¥å€ã§åããŠå ±åããããã®éå£çºçã¯ãã¬ãŒãããã®å°ååºä¹³é¡ã®èŒžå ¥ã«ããã®ãŒããã®ã§ããããã®éå£çºçã§ç€ºãããããã«ãè€æ°ã®åç©ããã®ç æ°ã«ææããå¯èœæ§ããããŸãããã®éå£çºçã§ã¯ã巚倧ãªè¢ããºããšãªã¹ããã®ãŠã€ã«ã¹ã®éœæ§åå¿ã瀺ããæçµçã«ã¯äžè¥¿éšã®è€æ°ã®å·ã§ããããšããŠå£²ãããŠãããã¬ãŒãªãŒããã°ã«ææãåºãããŸããïŒCDCã«ããïŒã47人ããã¬ãŒãªãŒããã°ãããã®ç æ°ã«ææãããããã¯éèŠãªæŽå²çäºå®ã§ãããšããã®ããä»åã®å€§æµè¡ã¯ãããããããžã®ææã§çºçããŠããããã§ãã±ãŒã¹ãŒããšããŠè¿œè·¡ã§ããåäœããªãã®ã§ããã¢ããªã«ä»¥å€ã§ã¯ããã€ãžã§ãªã¢ããæ¥ãæ è¡è ããæ°å¹Žåã«çºçããäŸããããçŸåšããã€ãžã§ãªã¢ã§ã¯ããããŸã§å ±åãããŠããããããã£ãšå€ãã®ç¿çãŠã€ã«ã¹ãæµè¡ããŠãããšèããããŠããŸãã
ç±³åœã§2019幎ã«18æ³ä»¥äžã察象ã«èªå¯ããã倩ç¶çãšãµã«çãäºé²ããã¯ã¯ãã³ãšããŠããã€ãšã«ã³ã»ãã«ãã£ãã¯ç€Ÿã®JynneosããããŸãã2ã€ç®ã®ã¯ã¯ãã³ã§ããEmergent Product Development瀟補ACAM2000ã¯å€©ç¶çãäºé²ããç¿çãããçšåºŠäºé²ã§ãããšèããããŠãããã©ã¡ãã®ã¯ã¯ãã³ããå®å šã«å®å šãšããããã§ã¯ãªãã®ã§ããã®ç æ°ã«ææãããªã¹ã¯ãé«ããšèãããã人ã«ã®ã¿èªå¯ãããŠããã 2003幎ã«ç±³åœã§çºçããã¢ã³ããŒããã¯ã¹ã§ã¯ãé«ãªã¹ã¯ãšèãããã人ã«å€©ç¶çã¯ã¯ãã³ãé åããŸããã
ç±³åœã¯ãå ¬è¡è¡çäžã®ç·æ¥äºæ ã«å¯ŸãããããžãšããŠããã§ã«æŠç¥çåœå®¶åèãšããŠã¯ã¯ãã³ã®äŸçµŠã確ä¿ããŠããŸããã倩ç¶çã®ç·æ¥äºæ ã«å¯ŸåŠãããããSNSã¯ç±³åœå šäººå£ã«æ¥çš®å¯èœãªå€©ç¶çã¯ã¯ãã³ãä¿æããŠããŸããããã«ãSNSã«ã¯ãå¿ èŠã«å¿ããŠå€©ç¶çææã®æ²»çã«æå ¥ã§ããæãŠã€ã«ã¹å€ããããŸãããšãä¿å¥ç€ŸäŒçŠç¥çã®åºå ±æ åœè ã¯é»åã¡ãŒã«ã§èªã£ããç§ã®æèŠã§ã¯ãç±³åœä¿å¥çãšãã€ãã³æ¿æš©ã«ãã£ãŠæ¿èªããã1å1900äžãã«ã®å€©ç¶çã¯ã¯ãã³è³Œå ¥ã¯ãçŸåšã®æ ªããã®ã¯ã¬ãŒãå ã®æŽå²çãªå è¡æ ªãšèããç°ãªãããšã瀺ãããŒã¿ããªãéããäžå¿ èŠãã€äžåœãªåºè²»ã§ãããšæãã
WHOã®Van Kerkhoveæ°ã¯ããããã®è£œåã®äžã«ã¯ãåç©å®éšã«ãŒã«ãšåŒã°ãããã®ãçšããŠèªå¯ããããã®ããããšææãããããã¯ã倩ç¶çãæµéããŠããªããããã¯ã¯ãã³ãè¬å€ã®äººã§ã®æå¹æ§ããã¹ãããããšãã§ãããåç©ã®æå¹æ§ããŒã¿ã代çšãšããŠäœ¿çšãããã®ã§ããããã®çµæããã®ãããªè£œåã¯èšåºè©Šéšã§ã®ã¿äœ¿çšããããšãã§ããããšåœŒå¥³ã¯èšã£ãã
ãéžæè¢ã¯ããããã ããããé©åã«äœ¿ãããããšã確èªããªããã°ãªããªããã¯ã¯ãã³ã«é¢ããããšã®ã²ãšã€ã¯ãããã¯ã¯ãã³ãå¿ èŠãšããã䜿çšããããªãããããæãå¿ èŠãšãã人ã ã®éã§äœ¿çšãããããšã確èªãããããšããããšã§ããä»ã¯ãŸã ååãªäŸçµŠããªãã®ã§ãããšåœŒå¥³ã¯èšããŸãã
ããã§ã圌女ã¯ããã®æµè¡ã¯æãããããšç¢ºä¿¡ããŠããŸãã
ãä»ãç§ãã¡ããã¹ãããšã¯ãæææ¡å€§ãé£ãæ¢ããããšã«éäžããããšã§ãããããŠãããã¯å¯èœã§ããé©åãªã¡ãã»ãŒãžã®çºä¿¡ãé©åãªæ€æ»...å¿ èŠãªéé¢ãšèšåºã±ã¢ãå»çåŸäºè ã®ä¿è·ãããã°å¯èœã§ãããšãŽã¡ã³ã»ã±ã«ã¯ããæ°ã¯è¿°ã¹ãã(STAT News)ã
ãã«ã»ã²ã€ããè³éãæäŸããGAVIã¯ããµã«çãããããå»çäžã®è
åšã«ã€ããŠãããã«ãã®è©äŸ¡ãçºè¡šããŠããã
ãã®ãµãã¹ã¿ãã¯ã®èªè
ã®å€ãã¯ããã®GAVIã®è
åšã®è©äŸ¡ã¯éåžžã«èªåŒµã«åã£ãŠãããšããç§ã®è©äŸ¡ã«é©ããªãã ãããäŸãã°ããã®èšäºã¯ç¿çãšãšãã©åºè¡ç±ãšã®éã«é¡äŒŒç¹ãäœãããšããŠããã
ãšãã©åºè¡ç±ã®ãããªãŠã€ã«ã¹ãšåæ§ã«ãææã¯ç å€éšãäœæ¶²ãåŒåžåšé£æ²«ãå¯å ·ãè¡£æãªã©ã®æ±æãããç©è³ªãšã®æ¥è§Šã«ãã£ãŠãè¿æ¥ããå Žæã§ããèµ·ãããŸããã
ãŸããèšäºã«ã¯æ¬¡ã®ãããªãã³ãäžäžã®åœæ å ±ãèšèŒãããŠããã
çç¶ã¯1ã¶æä»¥å ã«ç·©åãããããšãå€ããã10ä»¶ã«1ä»¶ã¯èŽåœçãšãªãå¯èœæ§ããããç¹ã«åäŸãããããããã
æè³æ Œã®å°éå®¶ã«ãããã¡ã¯ããã§ãã¯ã®çµæ
ãã®äž»åŒµã¯ãäžçä¿å¥æ©é¢ïŒWHOïŒã®ããŒã¿å ±åæžãéåžžã«åã£ãè§£éã§è¡šçŸãããã®ã§ããã
2020幎ãäžçä¿å¥æ©é¢ïŒWHOïŒã¯ããµã«çã®çãäŸ4,594ä»¶ããã¡æ»äº¡äŸ171ä»¶ïŒçäŸèŽæ»ç3.7%ïŒãå ±åããŸããã確èªã«ã¯PCRæ€æ»ãå¿ èŠã§ãããæµè¡å°ã§ã¯å®¹æã«å ¥æã§ããªããããçããšè¡šçŸããŠããã
ãã®ãããªæ å ±æäœãšæŠåšåã«ææãªèªè ã¯ããã®ã³ã¡ã³ãã«ã€ããŠããã«äºã€ã®éèŠãªããšã«æ°ãã€ãã ããã第äžã«ãå ±åãããŠãã3.7ïŒ ïŒ10ïŒ ã§ã¯ãªãïŒãšããæ»äº¡çã¯ã確å®çäŸã§ã¯ãªããçãçäŸã«ãããã®ã§ãããšããããšã§ããã第äºã«ããã®çš®ã®ãµã³ããªã³ã°ã¯ãããéçã®ã±ãŒã¹ã«éåžžã«åã£ãŠããããšã§ããã
ã§ã¯ãçç©åŠçè
åšã¯æ¬ç©ãªã®ã§ããããïŒå·®ãè¿«ã£ãŠããã®ã§ããããïŒäžççãªã¡ãã£ã¢ã«ãã倧ãããªå®£äŒã¯æ£åœåãããã®ã ãããïŒ
2æ¥åãç±³åœããè±åœã«ç§»åãããã空枯ã®ã©ãŠã³ãžã§åŸ
ã£ãŠãããšãCNNããã®ãè
åšãã«ã€ããŠæ¯ãåãããã«å ±éãã倩ç¶çã«èŠããæ£è
ãã¡ã®æŽå²çãªæ åãæµããŠãããããã¯å
¬è¡è¡çäžã®æææ¿æ²»ã®å
žåäŸã§ãããCNNã¯ãžã£ãŒããªãºã ãè£
ã£ãŠç¡è²¬ä»»ãªãããã¬ã³ã-èª€å ±ãšèª€å ±-ãæŸéããããšãèŽè²¬ãããã¹ãã ãšãããã¯æãã
çŸåšå ¥æå¯èœãªæ å ±ã«åºã¥ããšããµã«çã¯ã¢ããªã«ã§æµè¡ããŠãããŠã€ã«ã¹ãšç æ°ã§ãããåç©ãããããžã®ææåŸã«æ£çºçã«åºçŸããå žåçã«ã¯ãããšã®å¯æ¥ãªæ¥è§Šã«ãã£ãŠåºãŸããã®ã§ããããã®ç æ°ã¯ãå€å žçãªå ¬è¡è¡ç察çã«ãã£ãŠå®¹æã«å¶åŸ¡ããããšãã§ããŸããæ»äº¡çãé«ãã¯ãããŸãããé²åãæå³çãªéºäŒåæäœã«ãã£ãŠäœããã®éºäŒåå€åããªãéããé倧ãªçç©åŠçè åšãšã¯ãªãããéå»ã«è åšã®é«ãç åäœãšã¿ãªãããããšã¯ãããŸããã
ã ãããææãç œã£ãããèª€å ±ãåœæ å ±ãæµãã®ã¯ããããã
New Americanãšã®ç§ã®ã€ã³ã¿ãã¥ãŒã¯ãïŒRumbleã§ïŒèŠãããšãã§ããŸãã
"åœé£äžçä¿å¥æ©é¢ãšãã€ãã³æ¿æš©ã«ããå€§èŠæš¡ãªæš©å奪åã¯-äžççµæžãã©ãŒã©ã ãšãã«ã»ã²ã€ããèæ¯ã«-åœå®¶äž»æš©ãç Žå£ããå
šäœäž»çŸ©çæ¯é
ã«ããåäžäžçæ¿åºãæ§ç¯ããããšãããã®ã§ãããšãmRNAã®ãã€ãªãã¢ããããŒãã»ãããŒã³å士ã¯The New Americanèªã®Conversations That Matterçšã®Alex Newmanãšã®ã€ã³ã¿ãã¥ãŒã§èŠåããŠããŸããããã¯ãã€ãã³åŽã®ã匟åŸãã¹ãç¯çœªãã§ãããšãããããèš±ããšæ¥µç«¯ãªçµæã«ãªããšèŠåããŠããããããŒã³å士ã¯ãç¯çœªè
ã«è²¬ä»»ãåããããã®æš©å奪åã«ãã¹ãŠã®ã¢ã¡ãªã«äººãæµæããããåŒã³ãããŠããŸãã